3 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of CancerDigestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Adipose Tissue, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Thoracic Neoplasms, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, colonic disorder, colorectal cancer, colorectal neoplasm, connective tissue neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, liposarcoma, lung disorder, lung neoplasm, melanocytic neoplasm, melanoma, myxoid liposarcoma, neoplasm, neuroendocrine neoplasm, non-small cell lung carcinoma, osteosarcoma, primitive neuroectodermal tumor, rectal disorder, respiratory system disorder, respiratory tract neoplasm, sarcoma, skin disorder, skin neoplasm, synovial sarcoma, triple-negative breast carcinomaRecruitingPhase 12026-05-12NCT05492682
The Italian Transthyretin Amyloidosis Web-NetworkImmunoglobulin Light-chain Amyloidosis, Neoplasms by Histologic Type, Nutritional and Metabolic Diseases, amyloidosis, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, metabolic disease, monoclonal gammopathy, neoplasm, plasma cell neoplasm, proteostasis deficienciesRecruitingNot stated2026-03-27NCT05444920
Novel Risk Prediction Approaches for the Primary Prevention of Cardiovascular Diseases in Italy: the CVRISK-IT Trial (CVRISK-IT)Cardiovascular Risk; Genetic Cardiovascular RiskRecruitingNot applicable2026-01-14NCT06832644